Roberts v. the Future: Genetic Screening and the Future of Personal Autonomy
By New York Times,
New York Times
| 08. 28. 2005
III. Genetic Screening and the Future of Personal Autonomy
Every Supreme Court confirmation hearing since the election of Ronald Reagan has been marked by efforts -- nearly always unsuccessful -- to predict the nominee's views on Roe v. Wade. The Roberts hearings are unlikely to prove an exception. If Roberts is confirmed, he will have two opportunities in the next Supreme Court term to reveal some of his views about the potential implications of Roe -- in one case involving a teen-health exception in parental-notification laws and in another concerning the federal power to prosecute protesters at abortion clinics. Regardless of whether Roe v. Wade remains on the books in 10 or 20 years, however, America's political and legal disputes about reproduction may well have moved far beyond efforts to balance the interests of a fetus against the interests of a pregnant mother. Instead, the country will most likely be debating the use of sophisticated technologies involving genetic manipulation and reproductive cloning outside the womb -- controversial procedures that may prompt restrictions or bans by state legislatures or Congress. In...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...